Esomeprazole Sodium For Injection 40 Mg Dry Powder Injections Vial

What is Esomeprazole Sodium for Injection 40 Mg?

Esomeprazole Sodium for Injection 40 mg is an injectable formulation of esomeprazole, a proton pump inhibitor (PPI) that reduces gastric acid production. It may be used in clinical settings when parenteral acid-suppression therapy is appropriate under the approved product information. The listed presentation is intended for pharmaceutical sourcing enquiries, subject to confirmation of the product specification and documentation.

Uses and Indications

Esomeprazole reduces stomach acid and may be used for approved acid-related conditions, depending on the specific injectable product and local prescribing information. Potential clinical applications may include:

• Gastro-oesophageal reflux disease (GORD) in appropriate clinical circumstances.

• Acid suppression when oral administration is not suitable, where approved.

• Other approved indications specified in the product’s prescribing information.

Important: The precise indications for the 40 mg injectable presentation must be confirmed against its approved product information. Not every indication for oral esomeprazole automatically applies to an injectable formulation.

Benefits

• Targeted acid suppression: Reduces gastric acid secretion by inhibiting the gastric proton pump.

• Injectable presentation: May be suitable when oral administration is not feasible and parenteral treatment is clinically indicated.

• Established therapeutic class: Esomeprazole belongs to the proton pump inhibitor class.

• B2B sourcing support: Listed for pharmaceutical procurement enquiries, subject to availability and specification confirmation.

Side Effects

The adverse effects of esomeprazole vary according to the patient, duration of treatment and product formulation.

Common or recognised adverse effects

Possible adverse effects include:

• Headache.

• Abdominal discomfort.

• Nausea or vomiting.

• Diarrhoea or constipation.

• Injection-site reactions, depending on the formulation and administration.

Less common or serious adverse effects

• Severe hypersensitivity reactions.

• Significant or persistent diarrhoea.

• Kidney-related adverse reactions, including acute interstitial nephritis.

• Electrolyte disturbances or other complications associated with prolonged or clinically significant acid suppression.

The product-specific safety information should be reviewed before use. Serious or persistent symptoms require prompt medical assessment.

How Does It Work?

Esomeprazole inhibits the gastric hydrogen-potassium ATPase enzyme system, commonly known as the proton pump, in the acid-producing cells of the stomach. This reduces gastric acid secretion and helps control acidity-related symptoms and conditions. It does not act as an immediate neutraliser of acid already present in the stomach.

Dosage Guidelines

The appropriate dose and treatment duration depend on the approved indication, patient characteristics and product-specific prescribing information.

• Use only under the supervision of a qualified healthcare professional.

• Confirm the recommended dose and administration instructions from the approved product documentation.

• Preparation, dilution and administration must follow the specific product’s instructions.

• Do not assume that injectable and oral formulations have identical dosing instructions.

• Do not infer reconstitution volumes, infusion rates or compatibility from the 40 mg strength alone.

When Not to Use

Esomeprazole may be unsuitable for patients with:

• Known hypersensitivity to esomeprazole, other substituted benzimidazoles or relevant formulation ingredients.

• A contraindication or clinically significant interaction specified in the approved product information.

Additional precautions may apply to patients with certain medical conditions or those taking interacting medicines. A healthcare professional should assess suitability before treatment.

Drug and Product Interactions

Esomeprazole can interact with medicines whose absorption or activity is affected by gastric acidity or by metabolic pathways involving CYP2C19.

Relevant medicines may include:

• Clopidogrel: Esomeprazole may reduce the antiplatelet activity of clopidogrel; concomitant use should be reviewed against current prescribing guidance.

• Warfarin: Monitoring may be needed when used together.

• Certain antiretroviral medicines: Some combinations are contraindicated or not recommended.

• Methotrexate: High-dose treatment may require specific assessment.

• Medicines affected by gastric pH: Their absorption may change when gastric acid is suppressed.

A healthcare professional should review the patient’s complete medication list. Injectable compatibility with other medicines must be assessed separately from drug interactions.

Safety Advice

• Use only when clinically indicated and under appropriate medical supervision.

• Confirm allergy history and relevant medical conditions before treatment.

• Review potential interactions, particularly with medicines requiring careful monitoring.

• Monitor for unexpected or serious adverse reactions.

• Follow the approved product information for preparation and administration.

• Use the lowest effective dose for the clinically appropriate duration, as determined by the treating healthcare professional.

General Instructions

• Verify the product name, strength, vial integrity, batch details and expiry date before use.

• Ensure the product specification matches the intended clinical use.

• Preparation and administration should be performed by appropriately trained healthcare personnel.

• Follow product-specific instructions for reconstitution, dilution, administration and disposal.

• Do not use a vial if its integrity is compromised or the product fails the relevant acceptance checks.

Special Dietary and Lifestyle Tips

Lifestyle measures may support the management of acid-related conditions but do not replace prescribed treatment.

• Consider smaller meals if large meals aggravate reflux symptoms.

• Avoid lying down soon after eating if this triggers symptoms.

• Identify and limit personal food or drink triggers where relevant.

• Seek medical advice for persistent symptoms, difficulty swallowing, unexplained weight loss or gastrointestinal bleeding.

• Follow individual dietary guidance from the treating healthcare professional.

Comparison with Other Treatments

These treatments are not automatically interchangeable. Selection depends on the indication, patient factors, route of administration and approved prescribing information.

Precautions and Warnings

• Confirm the approved indications and administration instructions for the injectable formulation.

• Use caution in patients with a history of hypersensitivity to proton pump inhibitors.

• Review potential drug interactions before treatment.

• Consider relevant kidney-related adverse reactions and other warnings in the approved product information.

• Long-term acid suppression may be associated with certain nutritional, electrolyte and infection-related risks; relevance depends on treatment duration and patient factors.

• Do not infer regulatory approvals, manufacturing certifications, storage conditions or stability data without verified documentation.

Can I Use It With Other Medicines or Antibiotics?

Esomeprazole may be prescribed with other medicines when clinically appropriate, including as part of certain treatment regimens. However, suitability depends on the combination and the patient’s condition.

• Inform the healthcare professional about all medicines and supplements being used.

• Check for interactions with medicines such as clopidogrel, warfarin and selected antiretrovirals.

• Do not combine or mix injectable medicines in the same container or administration line unless compatibility is established for the specific products.

• Follow the approved instructions for administration and monitoring.

Storage

Store according to the labelled conditions and approved product specification. The precise storage temperature, light-protection requirements, shelf life and stability after reconstitution or dilution have not been supplied and should not be assumed.

Frequently Asked Questions

1. What is Esomeprazole Sodium for Injection 40 mg used for?

It is an injectable proton pump inhibitor formulation used for approved acid-related indications when parenteral treatment is appropriate.

2. How does esomeprazole work?

It inhibits the gastric proton pump, reducing the amount of acid produced by the stomach.

3. Is the injection the same as oral esomeprazole?

Both contain esomeprazole as the active drug, but their administration instructions and approved uses may differ. They should be used according to the relevant product information.

4. Can the injection be mixed with other medicines?

Only when compatibility has been established for the specific formulation and products. Follow the approved preparation and administration instructions.

5. What strength is listed?

The supplied product specification states 40 mg. Additional formulation and packaging details should be confirmed with the approved product documentation.

6. What are the possible side effects?

Potential effects include headache, gastrointestinal symptoms and administration-site reactions. Serious hypersensitivity or kidney-related reactions may also occur.

7. Is the product available for pharmaceutical export enquiries?

Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries. Availability, documentation and commercial terms are subject to confirmation.

8. Is the product leaflet available?

The pack insert or leaflet is available upon request, subject to confirmation of the relevant product documentation.